UiPath, Inc. (NYSE:PATH – Get Free Report) CEO Daniel Dines sold 45,000 shares of the business’s stock in a transaction dated Monday, June 23rd. The shares were sold at an average price of $12.10, for a total value of $544,500.00. Following the completion of the sale, the chief executive officer now owns 5,778,376 shares in the company, valued at $69,918,349.60. This represents a 0.77% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this link.
UiPath Trading Up 0.5%
Shares of NYSE PATH traded up $0.06 during midday trading on Monday, hitting $12.24. 6,592,186 shares of the company’s stock were exchanged, compared to its average volume of 10,447,516. The business’s fifty day moving average price is $12.19 and its two-hundred day moving average price is $12.56. The company has a market cap of $6.55 billion, a price-to-earnings ratio of -101.99, a PEG ratio of 15.96 and a beta of 1.06. UiPath, Inc. has a 12-month low of $9.38 and a 12-month high of $15.93.
UiPath (NYSE:PATH – Get Free Report) last released its quarterly earnings results on Thursday, May 29th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.10 by $0.01. The business had revenue of $356.62 million during the quarter, compared to analysts’ expectations of $332.17 million. UiPath had a negative net margin of 4.65% and a negative return on equity of 3.05%. The business’s quarterly revenue was up 6.4% compared to the same quarter last year. During the same quarter in the previous year, the company earned $0.13 EPS. Equities analysts expect that UiPath, Inc. will post -0.17 earnings per share for the current fiscal year.
Institutional Inflows and Outflows
Wall Street Analyst Weigh In
PATH has been the subject of several recent research reports. BMO Capital Markets lifted their target price on shares of UiPath from $11.50 to $15.50 and gave the stock a “market perform” rating in a research note on Friday, May 30th. Morgan Stanley lifted their price objective on shares of UiPath from $12.00 to $15.00 and gave the company an “equal weight” rating in a research note on Monday, June 2nd. Canaccord Genuity Group set a $16.00 target price on UiPath and gave the stock a “buy” rating in a research report on Monday, June 2nd. UBS Group reduced their price target on UiPath from $14.00 to $10.00 and set a “sell” rating for the company in a research report on Thursday, March 13th. Finally, Truist Financial increased their price objective on UiPath from $12.00 to $13.00 and gave the stock a “hold” rating in a report on Friday, May 30th. Two investment analysts have rated the stock with a sell rating, twelve have given a hold rating and two have assigned a buy rating to the company. According to MarketBeat, UiPath currently has a consensus rating of “Hold” and a consensus price target of $13.83.
Get Our Latest Research Report on PATH
About UiPath
UiPath Inc provides an end-to-end automation platform that offers a range of robotic process automation (RPA) solutions primarily in the United States, Romania, the United Kingdom, the Netherlands, and internationally. The company offers a suite of interrelated software to build, manage, run, engage, measure, and govern automation within the organization.
Featured Stories
- Five stocks we like better than UiPath
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- 3 Tickers Leading a Meme Stock Revival
- D-Wave Goes International With South Korea Partnership
- How to Capture the Benefits of Dividend Increases
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Receive News & Ratings for UiPath Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UiPath and related companies with MarketBeat.com's FREE daily email newsletter.